Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 286-288

  Clarke, Lorraine M ^a   Duerr, Ann ^b   Yeung, Kam Ha Anna ^b   Brockman, Susan ^b   Barhosa, Cibele ^b   Macasaet, Milagros ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENDOMETRIUM BIOPSY; FEMALE; FEMALE GENITAL SYSTEM; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VIRUS CULTURE; VIRUS ISOLATION; VIRUS REACTIVATION; VIRUS SHEDDING;

EID: 0030916216     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517268     Document Type: Article

References (16)

1. Center for Disease Control and Prevention. Pelvic inflammatory disease: guidelines for prevention and management. MMWR Morb Mortal Wkly Rep 1991;40(RR-5):1-25.
2. Velebil P, Wingo P, Xia Z, Wilcox L, Peterson H. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol 1995;86:764-9.
3. Eschenbach DA, Buchanan RM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975;293:166-71.
4. Wasserheit JN, Bell TA, Kiviat NB, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104:187-93.
5. Rice PA, Schachter J. Pathogenesis of pelvic inflammatory disease. JAMA 1991;266:2587-93.
6. Chandler SH, Holmes KK, Wentworth BB, et al. The epidemiology of cytomegaloviral infection in women attending a sexually transmitted disease clinic. J Infect Dis 1985;152:597-605.
7. Hager DW, Eschenbach DA, Spence M, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61:113-4.
8. Clarke LM, Duerr A, Feldman J, Sierra MF, Daidone BJ, Landesman SH. Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1 -seronegative and -seropositive women from an urban minority community. J Infect Dis 1996;173:77-82.
9. Cummings MC. Mycoplasmas. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington DC: American Society for Microbiology, 1992:8.24.3.1-8.
10. Kent PT, Kubica GP. Public health mycobacteriology. A guide for the level III laboratory. Washington, DC: Centers for Disease Control and Prevention, 1985:22-25; publication PB86-21654-6.
11. Citron DM, Murray PR. General processing of specimens for anaerobic bacteria. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991:488-94.
12. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-7.
13. Jordan MC, Rousseau WE, Noble GR, Stewart JA, Chin TOY. Association of cervical cytomegaloviruses with venereal disease. N Engl J Med 1975;288:932-4.
14. Saltzman RL, Quirk MR, Jordan MC. Disseminated cytomegalovirus infection: molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest 1988;81:75-81.
15. Ho M. Cytomegalovirus: biology and infection. New York: Plenum, 1982.
16. Mazzulli T, Rubin RH, Ferraro MJ, et al. Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol 1993:31:2824-7.